The Lipoprotein and Coronary Atherosclerosis Study (LCAS): Design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia

This publication has 79 references indexed in Scilit:

• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials
  The American Journal of Cardiology, 1995
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
  New England Journal of Medicine, 1995
• Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
  The Lancet, 1994
• Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
  Circulation, 1993
• Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease
  New England Journal of Medicine, 1990
• Serum lipids and lipoproteins after myocardial infarction: Associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study
  American Heart Journal, 1987
• Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.
  Circulation, 1977
• MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE
  The Lancet, 1977